STRATA Skin Sciences, Inc. (SSKN)
USD 2.59
(-1.19%)
USD 2.59
(-1.19%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.67 Million USD | -51.81% |
| 2022 | 5.54 Million USD | 58.99% |
| 2021 | 3.48 Million USD | 1.31% |
| 2020 | 3.44 Million USD | 13.78% |
| 2019 | 3.02 Million USD | 8.34% |
| 2018 | 2.79 Million USD | -7.15% |
| 2017 | 3 Million USD | 6.82% |
| 2016 | 2.81 Million USD | -31.76% |
| 2015 | 4.12 Million USD | -21.74% |
| 2014 | 5.27 Million USD | -6.32% |
| 2013 | 5.63 Million USD | 733.48% |
| 2012 | 675.6 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 69.75 Thousand USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.69 Million USD | -0.11% |
| 2024 Q1 | 2.69 Million USD | 0.82% |
| 2023 FY | 2.67 Million USD | -51.81% |
| 2023 Q1 | 5.69 Million USD | 2.67% |
| 2023 Q3 | 6.12 Million USD | 3.45% |
| 2023 Q2 | 5.92 Million USD | 3.97% |
| 2023 Q4 | 2.67 Million USD | -56.36% |
| 2022 Q4 | 5.54 Million USD | -2.03% |
| 2022 Q3 | 5.66 Million USD | 15.39% |
| 2022 FY | 5.54 Million USD | 58.99% |
| 2022 Q1 | 4.75 Million USD | 36.37% |
| 2022 Q2 | 4.9 Million USD | 3.13% |
| 2021 Q4 | 3.48 Million USD | 8.19% |
| 2021 Q1 | 3.31 Million USD | -3.83% |
| 2021 Q2 | 3.04 Million USD | -7.94% |
| 2021 Q3 | 3.22 Million USD | 5.77% |
| 2021 FY | 3.48 Million USD | 1.31% |
| 2020 Q4 | 3.44 Million USD | -1.66% |
| 2020 Q3 | 3.5 Million USD | 0.92% |
| 2020 Q2 | 3.47 Million USD | -0.03% |
| 2020 Q1 | 3.47 Million USD | 14.67% |
| 2020 FY | 3.44 Million USD | 13.78% |
| 2019 Q1 | 3.12 Million USD | 11.7% |
| 2019 Q3 | 3.58 Million USD | -0.58% |
| 2019 Q4 | 3.02 Million USD | -15.59% |
| 2019 FY | 3.02 Million USD | 8.34% |
| 2019 Q2 | 3.6 Million USD | 15.57% |
| 2018 Q2 | 2.41 Million USD | -20.34% |
| 2018 Q1 | 3.02 Million USD | 0.66% |
| 2018 Q4 | 2.79 Million USD | 12.3% |
| 2018 FY | 2.79 Million USD | -7.15% |
| 2018 Q3 | 2.48 Million USD | 3.11% |
| 2017 FY | 3 Million USD | 6.82% |
| 2017 Q1 | 2.67 Million USD | -5.22% |
| 2017 Q2 | 3.48 Million USD | 30.6% |
| 2017 Q3 | 3.53 Million USD | 1.32% |
| 2017 Q4 | 3 Million USD | -14.83% |
| 2016 FY | 2.81 Million USD | -31.76% |
| 2016 Q4 | 2.81 Million USD | -12.76% |
| 2016 Q3 | 3.22 Million USD | -13.99% |
| 2016 Q2 | 3.75 Million USD | -9.59% |
| 2016 Q1 | 4.15 Million USD | 0.58% |
| 2015 Q4 | 4.12 Million USD | 5.44% |
| 2015 Q3 | 3.91 Million USD | 14.84% |
| 2015 Q2 | 3.4 Million USD | -34.29% |
| 2015 Q1 | 5.18 Million USD | -1.65% |
| 2015 FY | 4.12 Million USD | -21.74% |
| 2014 Q2 | 3.94 Million USD | -30.12% |
| 2014 Q4 | 5.27 Million USD | -1.66% |
| 2014 Q3 | 5.36 Million USD | 35.9% |
| 2014 FY | 5.27 Million USD | -6.32% |
| 2014 Q1 | 5.64 Million USD | 0.3% |
| 2013 Q2 | 276.5 Thousand USD | -36.72% |
| 2013 FY | 5.63 Million USD | 733.48% |
| 2013 Q4 | 5.63 Million USD | 1973.36% |
| 2013 Q3 | 271.58 Thousand USD | -1.78% |
| 2013 Q1 | 436.96 Thousand USD | -35.32% |
| 2012 Q4 | 675.6 Thousand USD | 2.9% |
| 2012 Q2 | 473.45 Thousand USD | 18.26% |
| 2012 FY | 675.6 Thousand USD | 0.0% |
| 2012 Q3 | 656.56 Thousand USD | 38.67% |
| 2012 Q1 | 400.36 Thousand USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 FY | 69.75 Thousand USD | 0.0% |
| 2004 Q4 | 69.75 Thousand USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 19.245% |
| BrainsWay Ltd. | 3.71 Million USD | 28.087% |
| Cerus Corporation | 39.86 Million USD | 93.295% |
| Envoy Medical, Inc. | 1.4 Million USD | -90.385% |
| electroCore, Inc. | 2.16 Million USD | -23.75% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -484.902% |
| IceCure Medical Ltd | 2.27 Million USD | -17.495% |
| Inogen, Inc. | 21.84 Million USD | 87.761% |
| OrthoPediatrics Corp. | 105.85 Million USD | 97.475% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -861.511% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -267299900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 78.142% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -54.805% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1608.861% |
| Orthofix Medical Inc. | 222.16 Million USD | 98.797% |
| PAVmed Inc | 1.01 Million USD | -162.832% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 86.609% |
| RxSight, Inc. | 17.42 Million USD | 84.656% |
| Sight Sciences, Inc. | 7.84 Million USD | 65.945% |
| SI-BONE, Inc. | 20.24 Million USD | 86.799% |
| TELA Bio, Inc. | 13.16 Million USD | 79.692% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 90.86% |
| Vivos Therapeutics, Inc. | 1.00 USD | -267299900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 37.518% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -1062.174% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -13.455% |
| CVRx, Inc. | 10.98 Million USD | 75.662% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -585.251% |
| Bioventus Inc. | 91.33 Million USD | 97.073% |
| Venus Concept Inc. | 28.67 Million USD | 90.679% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -5.029% |
| LivaNova PLC | 147.88 Million USD | 98.193% |
| 908 Devices Inc. | 14.93 Million USD | 82.106% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 98.047% |
| Nemaura Medical Inc. | 1.75 Million USD | -52.321% |
| NeuroPace, Inc. | 11.21 Million USD | 76.164% |
| LENSAR, Inc. | 15.68 Million USD | 82.963% |
| Apyx Medical Corporation | 9.92 Million USD | 73.063% |
| Cutera, Inc. | 72.1 Million USD | 96.293% |
| BioSig Technologies, Inc. | -103 Thousand USD | 2695.146% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 94.237% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 66.212% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.314% |
| Axonics, Inc. | 79.94 Million USD | 96.656% |
| Outset Medical, Inc. | 49.21 Million USD | 94.569% |
| IRIDEX Corporation | 9.9 Million USD | 73.016% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 93.276% |
| IRadimed Corporation | 12.82 Million USD | 79.152% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -253.571% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -910.559% |
| Telesis Bio, Inc. | 4.02 Million USD | 33.59% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 41.946% |
| Varex Imaging Corporation | 277.5 Million USD | 99.037% |
| Quipt Home Medical Corp. | 18.32 Million USD | 85.414% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 84.035% |
| Dynatronics Corporation | 5.59 Million USD | 52.216% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 28.549% |
| Semler Scientific, Inc. | 445 Thousand USD | -500.674% |
| InMode Ltd. | 45.09 Million USD | 94.073% |
| Bruker Corporation | 968.3 Million USD | 99.724% |
| Cytosorbents Corporation | 3.68 Million USD | 27.367% |
| DexCom, Inc. | 559.6 Million USD | 99.522% |
| Align Technology, Inc. | 296.9 Million USD | 99.1% |
| Viveve Medical, Inc. | 1.47 Million USD | -81.59% |
| ZimVie Inc. | 79.6 Million USD | 96.642% |
| Movano Inc. | 1.51 Million USD | -76.669% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 95.609% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1608.861% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 98.308% |
| Profound Medical Corp. | 6.95 Million USD | 61.558% |
| Insulet Corporation | 402.6 Million USD | 99.336% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 81.987% |
| iCAD, Inc. | 917 Thousand USD | -191.494% |
| Nuwellis, Inc. | 1.99 Million USD | -33.851% |
| Biotricity, Inc. | 1.87 Million USD | -42.226% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 80.87% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -26.923% |
| PAVmed Inc. | 1.01 Million USD | -162.832% |
| BIOLASE, Inc. | 11.43 Million USD | 76.62% |
| Beyond Air, Inc. | 2.12 Million USD | -25.67% |
| FONAR Corporation | 2.71 Million USD | 1.563% |
| AxoGen, Inc. | 23.02 Million USD | 88.388% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 88.134% |
| Inari Medical, Inc. | 42.9 Million USD | 93.769% |
| UFP Technologies, Inc. | 70.19 Million USD | 96.192% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -324.839% |
| Tenon Medical, Inc. | 554 Thousand USD | -382.491% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -60.567% |
| AdaptHealth Corp. | 113.64 Million USD | 97.648% |
| Sintx Technologies, Inc. | 888 Thousand USD | -201.014% |
| NanoVibronix, Inc. | 2.73 Million USD | 2.16% |
| Quanterix Corporation | 22.36 Million USD | 88.048% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 81.996% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 95.284% |
| TransMedics Group, Inc. | 44.23 Million USD | 93.957% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 52.715% |
| NeuroMetrix, Inc. | 1.55 Million USD | -71.409% |
| Hyperfine, Inc. | 6.58 Million USD | 59.389% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 96.656% |
| Biomerica, Inc. | 2.37 Million USD | -12.5% |
| Bone Biologics Corporation | -328.84 Thousand USD | 912.847% |
| AVITA Medical, Inc. | 3.12 Million USD | 14.366% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 91.053% |